MPO and inflammatory bowel disease: Specifically, the study aimed to evaluate the effect of this combination therapy in alleviating IBD through measurements of changes in the intestinal microbiota, histopathological analyses, intestinal barrier function, cytokine profiles, and myeloperoxidase activity.